第一作者机构:[1]Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangdong Acad Med Sci, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
Li Y-S,Yang J-J,Yu Q.,et al.Subgroup analysis of first-line camrelizumab plus chemotherapy in brain metastases of NSCLC: Results from the CTONG 2003 trial[J].JOURNAL OF THORACIC ONCOLOGY.2025,20(3):
APA:
Li, Y-S,Yang, J-J,Yu, Q.,Bu, Q.,Lin, L....&Wu, Y-L.(2025).Subgroup analysis of first-line camrelizumab plus chemotherapy in brain metastases of NSCLC: Results from the CTONG 2003 trial.JOURNAL OF THORACIC ONCOLOGY,20,(3)
MLA:
Li, Y-S,et al."Subgroup analysis of first-line camrelizumab plus chemotherapy in brain metastases of NSCLC: Results from the CTONG 2003 trial".JOURNAL OF THORACIC ONCOLOGY 20..3(2025)